Michelle Andrews

Michelle Andrews is a contributing writer and former columnist for KFF Health News. She has been writing about health care for more than 15 years. Her work has appeared frequently in The New York Times, where she wrote the Money and Medicine column and contributed regular news and features. Her work has also been published in Money, Fortune Small Business, National Geographic and Women’s Health magazines, among others. Michelle previously worked as a senior writer at U.S. News & World Report and at SmartMoney magazines. She has a bachelor’s degree from the University of Wisconsin and a master’s in journalism from Columbia University.

Despite Katie Couric’s Advice, Doctors Say Ultrasound Breast Exams May Not Be Needed

When Katie Couric announced she had breast cancer, she urged women to get a mammogram — and, if they have dense breasts, to get supplemental screening by ultrasound. But medical experts point out that ultrasound and other auxiliary screenings haven’t been proven to do more than regular mammography in reducing mortality.

Employers Are Concerned About Covering Workers’ Mental Health Needs, Survey Finds

Nearly half of large employers report that increasing numbers of their workers were using mental health services, according to a KFF annual employer survey. Yet almost a third of those employers said their health plan’s network didn’t have enough behavioral health care providers for employees to have timely access to the care they need.

$80,000 and 5 ER Visits: Ectopic Pregnancy Takes a Toll Despite NY’s Liberal Abortion Law

If an embryo has implanted in a fallopian tube, ending the pregnancy is imperative to protect the patient’s life. Women’s health advocates have raised concerns that the needed treatment may be hampered by restrictive abortion laws in some states. Yet women seeking treatment in states with more liberal abortion laws may still find the process expensive and harrowing.

Newborns Get Routine Heel Blood Tests, but Should States Keep Those Samples?

Shortly after birth, babies are pricked in the heel so their blood can be tested for life-threatening conditions. States generally save leftover blood from those samples, and parents and privacy experts are concerned that information could be used without consent years later.

Lo que debes saber sobre Paxlovid para tratar covid, en especial, ¿debes tomarlo?

Desde que Paxlovid comenzó a estar disponible hace siete meses, ha eclipsado otras terapias disponibles para prevenir los síntomas graves de covid en pacientes de alto riesgo. Algunos médicos se apresuran a recetarlo, pero como ocurre con tanto sobre la pandemia de covid, hay controversia.

Everything You Need to Know About Paxlovid — Especially, Should You Take It?

Paxlovid has eclipsed other available therapies for preventing life-threatening covid symptoms in high-risk patients. But even as doctors praise its effectiveness, many say they have unanswered questions about prescribing the drug and want more and better data about it.